# Femto Technologies Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Femto Technologies Inc.).

## Overview

Femto Technologies Inc. is a Canadian-incorporated, U.S.-reporting technology company based in Israel that develops and markets consumer femtech devices and software products through its operating subsidiaries. Its business centers on the Sensera device and the Benefit CRM software platform, combining proprietary hardware, embedded software, and recurring software services.

## Products & services

• Sensera femtech device and related consumables
• Lubricant capsules and recurring replenishment sales
• Benefit CRM business software
• Customer relationship and sales management software services
• AI-related software services and integration

- **Femtech device** (40%) — Sensera is the company's proprietary women’s wellness device sold as a standalone product.
- **Consumables and subscriptions** (25%) — Lubricant capsules and related repeat purchases sold through replenishment and subscriptions.
- **CRM software** (25%) — Benefit CRM software for small and medium-sized businesses.
- **Software services** (10%) — Implementation, support, and related software services delivered through BYND.

- Sensera femtech device and related consumables
- Lubricant capsules and recurring replenishment sales
- Benefit CRM business software
- Customer relationship and sales management software services
- AI-related software services and integration

## Customers

Femto sells to consumer buyers for its Sensera wellness offering and to small and medium-sized businesses for its CRM software. The consumer side is driven by direct purchase of the device and repeat consumable orders, while the software side serves businesses seeking sales, personnel, marketing, and call-center workflow tools.

- **Consumer femtech buyers** (primary) — Buy Sensera devices and consumables for personal wellness use and repeat replenishment.
- **Small and medium-sized businesses** (primary) — Buy Benefit CRM to manage sales, personnel, marketing, call-center, and asset workflows.
- **Software integration and service clients** (secondary) — Buy implementation and related software services around the CRM platform and related tools.

- Consumers buying Sensera for women’s wellness use cases
- Repeat buyers of lubricant capsules and subscriptions
- SMBs purchasing Benefit CRM to manage daily operations
- Businesses needing sales, marketing, and call-center tools
- Software clients seeking workflow and asset-management features

## Geography

Femto’s corporate and operating footprint spans Israel, Canada, and the United States, with reported principal executive offices in Kiryat Motzkin, Israel and a head office address in Vancouver, British Columbia. The company’s products are marketed online and its software subsidiary operates from Israel, making geography important for product development, commercialization, and corporate structure.

- Principal executive offices are in Kiryat Motzkin, Israel
- Head office address is in Vancouver, British Columbia
- BYND Beyond Solutions Ltd. is Israel-based
- Sales are supported through the Sensera website and Shopify
- U.S. reporting structure reflects cross-border operations

## Strategy

Femto’s stated strategy is to develop and commercialize the Sensera device while also building Benefit CRM as a software business. The company is also seeking to strengthen its software capabilities and stay relevant as AI changes the software market.

- **Commercialize Sensera and related consumables** (short-term) — Creates a consumer product base with potential repeat revenue from replenishment sales.
- **Strengthen software capability** (medium-term) — Improves the company’s competitive position in CRM and services as software markets evolve.
- **Build recurring revenue streams** (medium-term) — Subscription and replenishment models can reduce dependence on one-time device sales.

- Develop and commercialize the Sensera device
- Grow recurring sales from consumables and subscriptions
- Expand Benefit CRM among SMB customers
- Add software capability through acquisition
- Adapt product offerings to AI-driven software change

## Risks

Femto faces execution risk because it is developing and commercializing new products while also trying to expand its software business. Its filings also indicate going-concern dependence on future financing and shareholder support, while the company’s consumer and software products compete in markets that are being reshaped by AI and fast-changing customer preferences.

- **Going-concern and financing dependence** [critical] — The filings state continuation depends on revenue generation and obtaining equity or debt financing.
- **Product commercialization risk** [high] — Sensera is still being developed and commercialized, so demand, adoption, and scaling remain uncertain.
- **Software competition and AI disruption** [high] — The company says software markets are changing significantly due to AI engines.
- **Revenue concentration in new offerings** [medium] — A small number of products and early-stage offerings can make results sensitive to launch timing.

- Going-concern dependence on financing and shareholder support
- New product commercialization risk for Sensera
- Consumer adoption risk for femtech products sold online
- Competition in CRM and software services
- AI-driven market change could erode software relevance

## Accounting

Femto reports under IFRS and highlights judgment in revenue recognition using the five-step IFRS 15 approach, collectability of receivables, financial instrument classification, and functional currency determination. Because the company combines a device business, consumables, subscriptions, and software services, the timing of revenue recognition and collectability assessments can materially affect reported results.

- **IFRS 15 revenue recognition** — Device sales, consumables, subscriptions, and services may not be recognized uniformly.
- **Collectability of receivables** — Bad-debt assumptions affect revenue quality and impairment charges.
- **Functional currency** — Can affect translation gains/losses and reported balance sheet amounts.
- **Equity method investment** — May affect carrying value and income from equity-accounted investees.

- IFRS 15 revenue recognition for device, consumables, and services
- Collectability estimates on receivables from buyers and partners
- Functional currency judgment across Israeli and Canadian entities
- Financial instrument classification and valuation
- Equity method accounting for the Gilad investment

---

*Last updated: 2026-09-28T12:03:37.567938+00:00*